Resistance to rifampicin: a review

Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis

(2014) F. B. Jamieson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?

(2013) T. Schon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activation and Products of the Cryptic Secondary Metabolite Biosynthetic Gene Clusters by Rifampin Resistance (rpoB) Mutations in Actinomycetes

(2013) Y. Tanaka et al.   JOURNAL OF BACTERIOLOGY

Structure of Escherichia coli RNA polymerase holoenzyme at last

(2013) L. B. Rothman-Denes   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis

(2012) Y. Pang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

(2012) Kristian Ängeby et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples

(2011) M. Villar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus

(2011) Yukiko Watanabe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In VitroActivity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea andClostridium difficile

(2010) David J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns

(2010) Audrey Tupin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

(2009) G. E. Louw et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance

(2009) Yasutaka Hoshino et al.   JOURNAL OF ANTIBIOTICS

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

(2008) M. Kurabachew et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activation of Dormant Bacterial Genes byNonomuraeasp. Strain ATCC 39727 Mutant-Type RNA Polymerase

(2008) Adelfia Talà et al.   JOURNAL OF BACTERIOLOGY